Guardant Health AMEA
Guardant Health AMEA is a precision oncology company focused on conquering cancer globally through proprietary blood and tissue tests, vast data sets, and advanced AI analytics. Their products provide critical insights to improve patient outcomes across all stages of cancer care, including early cancer screening, recurrence monitoring, and treatment selection for advanced cancer. The company operates in over 60 countries across Asia, Middle East, Africa, and beyond, with laboratories in the US, UK, China, Japan, Spain, and Italy. Guardant Health AMEA partners with laboratories and cancer centers worldwide to expand access to their liquid biopsy tests, positioning itself as a global leader in precision oncology.
Guardant Health AMEA
Guardant Health AMEA is a precision oncology company focused on conquering cancer globally through proprietary blood and tissue tests, vast data sets, and advanced AI analytics. Their products provide critical insights to improve patient outcomes across all stages of cancer care, including early cancer screening, recurrence monitoring, and treatment selection for advanced cancer. The company operates in over 60 countries across Asia, Middle East, Africa, and beyond, with laboratories in the US, UK, China, Japan, Spain, and Italy. Guardant Health AMEA partners with laboratories and cancer centers worldwide to expand access to their liquid biopsy tests, positioning itself as a global leader in precision oncology.